News

Medical Dialogues2h
Cardiac safety data of Tirzepatide released: Tirzepatide offers additional cardiac benefits over Dulaglutide in SURPASS-CVOT Trial
Topline results from the SURPASS-CVOT trial reveal that once-weekly tirzepatide (Mounjaro) has a cardiovascular risk profile ...
The American Journal of Managed Care15h
Experts Encourage Use of GLP-1s in Cardiovascular Care
Glucagon-like peptide-1 (GLP-1) inhibitors have proven effective in preventing cardiovascular events, leading to experts ...